ROG and ROP Related Headlines

Go Back

Aug 26, 2026 02:52PM Roche wins FDA nod for HER2 companion diagnostics in GEA
Aug 26, 2026 02:52PM Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA

ROG and ROP Related Press Releases

Go Back

Aug 26, 2026 02:52PM Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA

ROG and ROP Related SEC Filings

Go Back